Human Influenza B victoria virus, B/Athens.GR/11012/2025


EVAg

Originator
:
National Influenza Reference Laboratory of Southern Greece, Hellenic Pasteur Institute

Produced by
: HPI
Shipping From
: Athens - GR

Product Description

Ref-SKU:
019V-06281
Human Influenza B victoria virus isolated in 2024/2025 season in Greece. The viral isolate can be shipped in dry ice or freeze dried. Infectious cell culture supernatant preserved in Viral Storage Medium -80°C. To confirm its identity the hemagglutinin and neuraminidase genes have been sequenced by sanger sequencing method and confirmed by WGS.
Product Risk Group: 
Virus name: 

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
500 ul

In stock

800,00 €
(Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

GMO: 
No
Virus host type: 
Infectivity Test: 
checked by qRT-PCR on culture supernatant
Viral titer: 
HA titer 1:32
Production cell line: 
Virus Cultivability: 
Passage: 
1st passage
Identification technique: 
sanger sequencing
Shipping conditions: 
IATA Classification: 

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Tuesday, 11 February, 2025
Country of collection: 
Suspected epidemiological origin : 
Isolation technique: 
MDCK cell culture